United States · FDA National Drug Code directory
Lantus Solostar
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0088-2219_4e220385-b760-4a64-a1ca-84bd2bebe448
- Product NDC
- 0088-2219
- Form
- INJECTION, SOLUTION
- Composition / generic term
- insulin glargine
- Labeler
- sanofi-aventis U.S. LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20090923
- Source listing expiry
- 20261231
Source-listed ingredients
- INSULIN GLARGINE — 100 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (0088-2219-00) / 3 mL in 1 SYRINGE · 0088-2219-00
- 5 SYRINGE in 1 CARTON (0088-2219-05) / 3 mL in 1 SYRINGE (0088-2219-01) · 0088-2219-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →